Prognostic impact of posttransplant FDG PET/CT scan in multiple myeloma

Multiple myeloma (MM) is a heterogeneous disease that may be evaluated by a broad array of imaging and laboratory techniques to measure disease activity and predict prognosis. Fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) scanning has been shown to be predictive...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Blood Adv
Egile Nagusiak: Kaddoura, Marcella, Dingli, David, Buadi, Francis K., Lacy, Martha Q., Gertz, Morie A., Dispenzieri, Angela, Kapoor, Prashant, Hwa, Lisa, Fonder, Amie, Hobbs, Miriam, Hayman, Suzanne, Lust, John, Leung, Nelson, Go, Ronald S., Lin, Yi, Gonsalves, Wilson, Kourelis, Taxiarchis, Warsame, Rahma, Kyle, Robert A., Broski, Stephen M., Rajkumar, Vincent, Kumar, Shaji
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Hematology 2021
Gaiak:
Lymphoid Neoplasia
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8288674/
https://ncbi.nlm.nih.gov/pubmed/34242392
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020004131
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak